Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein a-ii promoter: Molecular study in a 1135-member familial hypercholesterolemia kindred

Daisuke Takada, Mitsuru Emi, Yoichi Ezura, Yukiko Nobe, Katsumi Kawamura, Yasuhiko Iino, Yasuo Katayama, Yuanpei Xin, Lily L. Wu, Stacey Larringa-Shum, Susan H. Stephenson, Steven Hunt, Paul N. Hopkins

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Lipid and lipoprotein concentrations in plasma generally reflect complex influences of multiple genetic loci. Even an autosomal dominant disorder, familial hypercholesterolemia (FH), is characterized by phenotypic heterogeneity, as low-density lipoprotein (LDL) levels vary widely within the same pedigree. Molecular screening for LDL receptor (LDLR) mutations among 75 patients with clinically apparent FH led to identification of a novel splice-site mutation (IVS14+1 G>A) shared by 14 patients. Genealogical research confirmed that all 14 carriers were part of the same 1135-member pedigree with a common ancestor. The mutation resulted in an abruptly truncated LDLR protein, reducing functional LDLR activity by half in heterozygous carriers of the mutant allele. Of the 208 members of the kindred who were screened for the presence of this LDLR mutation, we identified 94 carriers and 114 noncarriers. Nine principal apolipoprotein genes that might affect LDL cholesterol differentially according to LDL-receptor status were examined in this pedigree. Strikingly lower total cholesterol and LDL-cholesterol values were observed among the majority of the LDLR mutation carriers who were simultaneously homozygous for the -265C variant of apoA-II (total cholesterol: 324 ± 8 vs 244 ± 19mg/dl, P = 0.0015; LDL-cholesterol: 237 ± 8 vs 155 ± 18mg/dl, P = 0.0008). In vitro transfection assays showed that transcriptional activity of the apoA-II promoter was reduced by 30% in the -265C variant as compared with the -265T variant. We thus concluded that one variant of the apoA-II gene was associated with reduced plasma LDL cholesterol only in FH patients.

Original languageEnglish
Pages (from-to)656-664
Number of pages9
JournalJournal of Human Genetics
Volume47
Issue number12
DOIs
Publication statusPublished - 2002
Externally publishedYes

Fingerprint

Hyperlipoproteinemia Type II
Apolipoproteins
LDL Receptors
Apolipoprotein A-II
LDL Cholesterol
Mutation
Pedigree
Genes
Cholesterol
Genetic Loci
LDL Lipoproteins
Lipoproteins
Transfection
Alleles
Lipids
Research
Proteins

Keywords

  • Apolipoprotein A-II
  • Familial hypercholesterolemia
  • Gene interaction
  • LDL receptor
  • Modifier gene

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein a-ii promoter : Molecular study in a 1135-member familial hypercholesterolemia kindred. / Takada, Daisuke; Emi, Mitsuru; Ezura, Yoichi; Nobe, Yukiko; Kawamura, Katsumi; Iino, Yasuhiko; Katayama, Yasuo; Xin, Yuanpei; Wu, Lily L.; Larringa-Shum, Stacey; Stephenson, Susan H.; Hunt, Steven; Hopkins, Paul N.

In: Journal of Human Genetics, Vol. 47, No. 12, 2002, p. 656-664.

Research output: Contribution to journalArticle

Takada, D, Emi, M, Ezura, Y, Nobe, Y, Kawamura, K, Iino, Y, Katayama, Y, Xin, Y, Wu, LL, Larringa-Shum, S, Stephenson, SH, Hunt, S & Hopkins, PN 2002, 'Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein a-ii promoter: Molecular study in a 1135-member familial hypercholesterolemia kindred', Journal of Human Genetics, vol. 47, no. 12, pp. 656-664. https://doi.org/10.1007/s100380200101
Takada, Daisuke ; Emi, Mitsuru ; Ezura, Yoichi ; Nobe, Yukiko ; Kawamura, Katsumi ; Iino, Yasuhiko ; Katayama, Yasuo ; Xin, Yuanpei ; Wu, Lily L. ; Larringa-Shum, Stacey ; Stephenson, Susan H. ; Hunt, Steven ; Hopkins, Paul N. / Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein a-ii promoter : Molecular study in a 1135-member familial hypercholesterolemia kindred. In: Journal of Human Genetics. 2002 ; Vol. 47, No. 12. pp. 656-664.
@article{2a90162fc91c4128a14bec27d89b1c2f,
title = "Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein a-ii promoter: Molecular study in a 1135-member familial hypercholesterolemia kindred",
abstract = "Lipid and lipoprotein concentrations in plasma generally reflect complex influences of multiple genetic loci. Even an autosomal dominant disorder, familial hypercholesterolemia (FH), is characterized by phenotypic heterogeneity, as low-density lipoprotein (LDL) levels vary widely within the same pedigree. Molecular screening for LDL receptor (LDLR) mutations among 75 patients with clinically apparent FH led to identification of a novel splice-site mutation (IVS14+1 G>A) shared by 14 patients. Genealogical research confirmed that all 14 carriers were part of the same 1135-member pedigree with a common ancestor. The mutation resulted in an abruptly truncated LDLR protein, reducing functional LDLR activity by half in heterozygous carriers of the mutant allele. Of the 208 members of the kindred who were screened for the presence of this LDLR mutation, we identified 94 carriers and 114 noncarriers. Nine principal apolipoprotein genes that might affect LDL cholesterol differentially according to LDL-receptor status were examined in this pedigree. Strikingly lower total cholesterol and LDL-cholesterol values were observed among the majority of the LDLR mutation carriers who were simultaneously homozygous for the -265C variant of apoA-II (total cholesterol: 324 ± 8 vs 244 ± 19mg/dl, P = 0.0015; LDL-cholesterol: 237 ± 8 vs 155 ± 18mg/dl, P = 0.0008). In vitro transfection assays showed that transcriptional activity of the apoA-II promoter was reduced by 30{\%} in the -265C variant as compared with the -265T variant. We thus concluded that one variant of the apoA-II gene was associated with reduced plasma LDL cholesterol only in FH patients.",
keywords = "Apolipoprotein A-II, Familial hypercholesterolemia, Gene interaction, LDL receptor, Modifier gene",
author = "Daisuke Takada and Mitsuru Emi and Yoichi Ezura and Yukiko Nobe and Katsumi Kawamura and Yasuhiko Iino and Yasuo Katayama and Yuanpei Xin and Wu, {Lily L.} and Stacey Larringa-Shum and Stephenson, {Susan H.} and Steven Hunt and Hopkins, {Paul N.}",
year = "2002",
doi = "10.1007/s100380200101",
language = "English",
volume = "47",
pages = "656--664",
journal = "Journal of Human Genetics",
issn = "1434-5161",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein a-ii promoter

T2 - Molecular study in a 1135-member familial hypercholesterolemia kindred

AU - Takada, Daisuke

AU - Emi, Mitsuru

AU - Ezura, Yoichi

AU - Nobe, Yukiko

AU - Kawamura, Katsumi

AU - Iino, Yasuhiko

AU - Katayama, Yasuo

AU - Xin, Yuanpei

AU - Wu, Lily L.

AU - Larringa-Shum, Stacey

AU - Stephenson, Susan H.

AU - Hunt, Steven

AU - Hopkins, Paul N.

PY - 2002

Y1 - 2002

N2 - Lipid and lipoprotein concentrations in plasma generally reflect complex influences of multiple genetic loci. Even an autosomal dominant disorder, familial hypercholesterolemia (FH), is characterized by phenotypic heterogeneity, as low-density lipoprotein (LDL) levels vary widely within the same pedigree. Molecular screening for LDL receptor (LDLR) mutations among 75 patients with clinically apparent FH led to identification of a novel splice-site mutation (IVS14+1 G>A) shared by 14 patients. Genealogical research confirmed that all 14 carriers were part of the same 1135-member pedigree with a common ancestor. The mutation resulted in an abruptly truncated LDLR protein, reducing functional LDLR activity by half in heterozygous carriers of the mutant allele. Of the 208 members of the kindred who were screened for the presence of this LDLR mutation, we identified 94 carriers and 114 noncarriers. Nine principal apolipoprotein genes that might affect LDL cholesterol differentially according to LDL-receptor status were examined in this pedigree. Strikingly lower total cholesterol and LDL-cholesterol values were observed among the majority of the LDLR mutation carriers who were simultaneously homozygous for the -265C variant of apoA-II (total cholesterol: 324 ± 8 vs 244 ± 19mg/dl, P = 0.0015; LDL-cholesterol: 237 ± 8 vs 155 ± 18mg/dl, P = 0.0008). In vitro transfection assays showed that transcriptional activity of the apoA-II promoter was reduced by 30% in the -265C variant as compared with the -265T variant. We thus concluded that one variant of the apoA-II gene was associated with reduced plasma LDL cholesterol only in FH patients.

AB - Lipid and lipoprotein concentrations in plasma generally reflect complex influences of multiple genetic loci. Even an autosomal dominant disorder, familial hypercholesterolemia (FH), is characterized by phenotypic heterogeneity, as low-density lipoprotein (LDL) levels vary widely within the same pedigree. Molecular screening for LDL receptor (LDLR) mutations among 75 patients with clinically apparent FH led to identification of a novel splice-site mutation (IVS14+1 G>A) shared by 14 patients. Genealogical research confirmed that all 14 carriers were part of the same 1135-member pedigree with a common ancestor. The mutation resulted in an abruptly truncated LDLR protein, reducing functional LDLR activity by half in heterozygous carriers of the mutant allele. Of the 208 members of the kindred who were screened for the presence of this LDLR mutation, we identified 94 carriers and 114 noncarriers. Nine principal apolipoprotein genes that might affect LDL cholesterol differentially according to LDL-receptor status were examined in this pedigree. Strikingly lower total cholesterol and LDL-cholesterol values were observed among the majority of the LDLR mutation carriers who were simultaneously homozygous for the -265C variant of apoA-II (total cholesterol: 324 ± 8 vs 244 ± 19mg/dl, P = 0.0015; LDL-cholesterol: 237 ± 8 vs 155 ± 18mg/dl, P = 0.0008). In vitro transfection assays showed that transcriptional activity of the apoA-II promoter was reduced by 30% in the -265C variant as compared with the -265T variant. We thus concluded that one variant of the apoA-II gene was associated with reduced plasma LDL cholesterol only in FH patients.

KW - Apolipoprotein A-II

KW - Familial hypercholesterolemia

KW - Gene interaction

KW - LDL receptor

KW - Modifier gene

UR - http://www.scopus.com/inward/record.url?scp=12244278253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12244278253&partnerID=8YFLogxK

U2 - 10.1007/s100380200101

DO - 10.1007/s100380200101

M3 - Article

C2 - 12522687

AN - SCOPUS:12244278253

VL - 47

SP - 656

EP - 664

JO - Journal of Human Genetics

JF - Journal of Human Genetics

SN - 1434-5161

IS - 12

ER -